The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes
The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes
Recruiting · NCT06318442 · Registry updated 2024-10-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes | Steroid Induced Hyperglycemia; Steroid-Induced Diabetes | Recruiting | Not applicable | 2024-10-02 | NCT06318442 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Imperial College London | 220 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Imperial College Healthcare NHS Trust | London | United Kingdom | 41 |